Proteomics International Pty Ltd

Proteomics International is a medical technology company at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics – the industrial scale study of the structure and function of proteins. Our mission is to improve the quality of lives by the creation and application of innovative tools that enable the proactive treatment of disease.

Proteomics International has developed a proprietary mass spectrometry based technology platform for discovery, verification and analytical validation of protein biomarkers. Promarker™ is a ground-breaking platform technology that takes advantage of the ubiquity of proteins in the human body.

The Promarker™ platform uses mass spectrometry-based technology to identify these proteins that can be used as biological markers of a particular disease and/or other conditions.

Learn more at proteomics.com.au

View Site